PERCEPTIVE ADVISORS LLC
Q3 2026 13F-HR Holdings
Net value change ($000)
-921,544
(-13.8%)
New positions
23
Sold out positions
24
Turnover %
25.5%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| FREENOME INC | 198,545 | NEW |
| AMLX | 158,002 | 105.5% |
| WAT | 59,318 | NEW |
| IRD | 43,560 | NEW |
| GLPG | 36,837 | NEW |
| ABT | 34,119 | NEW |
| BLOSSOMHILL THERAPEUTICS INC | 33,779 | NEW |
| MMED | 25,700 | NEW |
| NRIX | 22,548 | 21.5% |
| SEPN | 22,205 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| NUVL | -195,192 | -100.0% |
| APGE | -173,626 | -100.0% |
| PRAX | -91,951 | -13.5% |
| SYRE | -91,383 | -23.8% |
| Ascendis Pharma AS | -89,046 | -28.7% |
| CELC | -81,634 | -24.4% |
| KARDIGAN INC | -74,626 | -38.2% |
| BIIB | -53,339 | -89.4% |
| ROIV | -48,038 | -16.8% |
| RYTM | -46,019 | -16.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
399,916
(7.0% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|